Literature DB >> 19480409

Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia.

Carlos A Valdez1, Jonathan C Tripp, Yukiko Miyamoto, Jaroslaw Kalisiak, Petr Hruz, Yolanda S Andersen, Sabrina E Brown, Karina Kangas, Leo V Arzu, Barbara J Davids, Frances D Gillin, Jacqueline A Upcroft, Peter Upcroft, Valery V Fokin, Diane K Smith, K Barry Sharpless, Lars Eckmann.   

Abstract

Infections with the n class="Disease">diarrheagenic pathogen, Giardia lamblia, are commonly treated with the 5-nitroimidazole (5-NI) metronidazole (Mz), and yet treatment failures and Mz resistance occur. Using a panel of new 2-ethenyl and 2-ethanyl 5-NI derivatives, we found that compounds with a saturated bridge between the 5-NI core and a pendant ring system exhibited only modestly increased antigiardial activity and could not overcome Mz resistance. By contrast, olefins with a conjugated bridge connecting the core and a substituted phenyl or heterocyclic ring showed greatly increased antigiardial activity without toxicity, and several overcame Mz resistance and were more effective than Mz in a murine giardiasis model. Determination of the half-wave potential of the initial one-electron transfer by cyclic voltammetry revealed that easier redox activation correlated with greater antigiardial activity and capacity to overcome Mz resistance. These studies show the potential of combining systematic synthetic approaches with biological and electrochemical evaluations in developing improved 5-NI drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19480409      PMCID: PMC2766634          DOI: 10.1021/jm900356n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  29 in total

1.  Model systems for flavoenzyme activity: relationships between cofactor structure, binding and redox properties.

Authors:  Yves-Marie Legrand; Mark Gray; Graeme Cooke; Vincent M Rotello
Journal:  J Am Chem Soc       Date:  2003-12-24       Impact factor: 15.419

2.  Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteria.

Authors:  B Rouveix
Journal:  J Antimicrob Chemother       Date:  2007-06       Impact factor: 5.790

3.  Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum.

Authors:  Hanno Troeger; Hans-Joerg Epple; Thomas Schneider; Ulrich Wahnschaffe; Reiner Ullrich; Gerd-Dieter Burchard; Tomas Jelinek; Martin Zeitz; Michael Fromm; Joerg-Dieter Schulzke
Journal:  Gut       Date:  2006-08-25       Impact factor: 23.059

Review 4.  An updated review on Cryptosporidium and Giardia.

Authors:  David B Huang; A Clinton White
Journal:  Gastroenterol Clin North Am       Date:  2006-06       Impact factor: 3.806

Review 5.  Nitroimidazole drugs--action and resistance mechanisms. I. Mechanisms of action.

Authors:  D I Edwards
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

6.  Inhibition of pyruvate-ferredoxin oxidoreductase gene expression in Giardia lamblia by a virus-mediated hammerhead ribozyme.

Authors:  M Dan; A L Wang; C C Wang
Journal:  Mol Microbiol       Date:  2000-04       Impact factor: 3.501

Review 7.  Giardiasis as a re-emerging infectious disease and its zoonotic potential.

Authors:  R C Thompson
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

8.  An Experimental and Theoretical Study of the Substituent Effects on the Redox Properties of 2-[(R-phenyl)amine]-1,4-naphthalenediones in Acetonitrile.

Authors:  M. Aguilar-Martínez; G. Cuevas; M. Jiménez-Estrada; I. González; B. Lotina-Hennsen; N. Macías-Ruvalcaba
Journal:  J Org Chem       Date:  1999-05-14       Impact factor: 4.354

9.  Altered uptake of metronidazole in vitro by stocks of Giardia intestinalis with different drug sensitivities.

Authors:  P F Boreham; R E Phillips; R W Shepherd
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

10.  Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection.

Authors:  Kurt Hanevik; Trygve Hausken; Mette Helvik Morken; Elisabeth Astrup Strand; Kristine Mørch; Peter Coll; Lars Helgeland; Nina Langeland
Journal:  J Infect       Date:  2007-10-26       Impact factor: 6.072

View more
  20 in total

1.  A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro.

Authors:  Linda A Dunn; Anita G Burgess; Kenia G Krauer; Lars Eckmann; Patrice Vanelle; Maxime D Crozet; Frances D Gillin; Peter Upcroft; Jacqueline A Upcroft
Journal:  Int J Antimicrob Agents       Date:  2010-04-24       Impact factor: 5.283

2.  Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.

Authors:  Janelle M Wright; Linda A Dunn; Zygmunt Kazimierczuk; Anita G Burgess; Kenia G Krauer; Peter Upcroft; Jacqueline A Upcroft
Journal:  Parasitol Res       Date:  2010-06-09       Impact factor: 2.289

3.  High-throughput Giardia lamblia viability assay using bioluminescent ATP content measurements.

Authors:  Catherine Z Chen; Liudmila Kulakova; Noel Southall; Juan J Marugan; Andrey Galkin; Christopher P Austin; Osnat Herzberg; Wei Zheng
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

4.  Development of metronidazole-resistant lines of Blastocystis sp.

Authors:  L A Dunn; K S W Tan; P Vanelle; T Juspin; M D Crozet; T Terme; P Upcroft; J A Upcroft
Journal:  Parasitol Res       Date:  2012-02-24       Impact factor: 2.289

Review 5.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

6.  Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia.

Authors:  Noa Tejman-Yarden; Maya Millman; Tineke Lauwaet; Barbara J Davids; Frances D Gillin; Linda Dunn; Jacqueline A Upcroft; Yukiko Miyamoto; Lars Eckmann
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

7.  O(2)-dependent efficacy of novel piperidine- and piperazine-based chalcones against the human parasite Giardia intestinalis.

Authors:  Vijay Bahadur; Daniela Mastronicola; Hemandra Kumar Tiwari; Yogesh Kumar; Micol Falabella; Leopoldo Paolo Pucillo; Paolo Sarti; Alessandro Giuffrè; Brajendra Kumar Singh
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

8.  A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia.

Authors:  Noa Tejman-Yarden; Yukiko Miyamoto; David Leitsch; Jennifer Santini; Anjan Debnath; Jiri Gut; James H McKerrow; Sharon L Reed; Lars Eckmann
Journal:  Antimicrob Agents Chemother       Date:  2013-02-12       Impact factor: 5.191

9.  Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity.

Authors:  Yukiko Miyamoto; Jaroslaw Kalisiak; Keith Korthals; Tineke Lauwaet; Dae Young Cheung; Ricardo Lozano; Eduardo R Cobo; Peter Upcroft; Jacqueline A Upcroft; Douglas E Berg; Frances D Gillin; Valery V Fokin; K Barry Sharpless; Lars Eckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

10.  Treatment of giardiasis: current status and future directions.

Authors:  Richard R Watkins; Lars Eckmann
Journal:  Curr Infect Dis Rep       Date:  2014-02       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.